Protective Mechanisms of Mitochondria and Heart Function in Diabetes

Antioxidants and Redox Signaling

Volumn 22, Issue 17, 2015, Pages 1563-1586

  Aon, Miguel A ^a   Tocchetti, Carlo G ^a,b   Bhatt, Niraj ^a   Paolocci, Nazareno ^a   Cortassa, Sonia ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FAT DROPLET; GLUCOSE; GLUTATHIONE; MITOCHONDRIAL DNA; THIOREDOXIN; FATTY ACID;

CELL ENERGY; CELL FUNCTION; CELL PROTECTION; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DIABETIC PATIENT; HEART FUNCTION; HEART MITOCHONDRION; HEART MUSCLE METABOLISM; HEART OUTPUT; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; LIPID STORAGE; MITOCHONDRIAL ENERGY TRANSFER; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION UNCOUPLING; OXIDATIVE STRESS; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW; UPREGULATION; ANIMAL; CARDIAC MUSCLE; METABOLISM;

ANIMALS; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHIES; DNA, MITOCHONDRIAL; FATTY ACIDS; GLUCOSE; HUMANS; MITOCHONDRIA, HEART; MYOCARDIUM; OXIDATION-REDUCTION;

EID: 84930677776     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2014.6123     Document Type: Review

References (219)

1. Anderson EJ, Kypson AP, Rodriguez E, Anderson CA, Lehr EJ, and Neufer PD. Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart. J Am Coll Cardiol 54: 1891-1898, 2009.
2. Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, Lin CT, Price JW, 3rd, Kang L, Rabinovitch PS, Szeto HH, Houmard JA, Cortright RN, Wasserman DH, and Neufer PD. Mitochondrial H2 O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 119: 573-581, 2009.
3. Aon MA. Complex systems biology of networks: the riddle and the challenge. In: Systems Biology of Metabolic and Signaling Networks. Energy, Mass and Information Transfer, edited by Aon MA, Saks V, and Schlattner, U. Heidelberg, New York, Dordrecht, London: Springer- Verlag Berlin Heidelberg, 2013, pp. 19-35.
4. Aon MA, Bhatt N, and Cortassa S. Mitochondrial and cellular mechanisms for managing lipid excess. Front Physiol 5: 1-13, 2014.
5. Aon MA, Cortassa S, Maack C, and O'Rourke B. Sequential opening of mitochondrial ion channels as a function of glutathione redox thiol status. J Biol Chem 282: 21889-21900, 2007.
6. Aon MA, Cortassa S, and O'Rourke B. Percolation and criticality in a mitochondrial network. Proc Natl Acad Sci U S A 101: 4447-4452, 2004.
7. Aon MA, Cortassa S, and O'Rourke B. Redox-optimized ROS balance: a unifying hypothesis. Biochim Biophys Acta 1797: 865-877, 2010.
8. Aon MA, Stanley BA, Sivakumaran V, Kembro JM, O'Rourke B, Paolocci N, and Cortassa S. Glutathione/thioredoxin systems modulate mitochondrial H2O2 emission: an experimental-computational study. J Gen Physiol 139: 479-491, 2012.
9. Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, and Gonzalez FJ. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem 273: 5678-5684, 1998.
10. Balaban RS, Nemoto S, and Finkel T. Mitochondria, oxidants, and aging. Cell 120: 483-495, 2005.
11. Barger PM and Kelly DP. PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovasc Med 10: 238-245, 2000.
12. Belke DD, Larsen TS, Lopaschuk GD, and Severson DL. Glucose and fatty acid metabolism in the isolated working mouse heart. Am J Physiol 277: R1210-R1217, 1999.
13. Bell DSH. Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care 26: 2433-2441, 2003.
14. Bers DM. Altered cardiac myocyte Ca regulation in heart failure. Physiology (Bethesda) 21: 380-387, 2006.
15. Bhatt N, Aon MA, Shen XX, O'Rourke B, Gao WD, and Cortassa S. Redox-dependent differential optimization of contractile work in cardiac muscle from diabetic rat under hyperglycemia. Biophys J 104: 303A, Suppl. 1, 2013.
16. Bhatt N, Aon MA, Tocchetti CG, Shen XX, Dey S, Ramirez -Correa G, O'Rourke B, Gao WD, and Cortassa S. Restoring redox balance enhances contractility in heart trabeculae from type 2 diabetic rats exposed to high glucose. Am J Physiol Heart Circ Physiol 308: H291-H302, 2015.
17. Bianchi C, Genova ML, Parenti Castelli G, and Lenaz G. The mitochondrial respiratory chain is partially organized in a supercomplex assembly: kinetic evidence using flux control analysis. J Biol Chem 279: 36562-36569, 2004.
18. Bing RJ and Michal G. Myocardial efficiency. Ann N Y Acad Sci 72: 555-558, 1959.
19. Birch-Machin MA and Turnbull DM. Assaying mitochondrial respiratory complex activity in mitochondria isolated from human cells and tissues. Methods Cell Biol 65: 97-117, 2001.
20. Boardman N, Hafstad AD, Larsen TS, Severson DL, and Aasum E. Increased O2 cost of basal metabolism and excitation-contraction coupling in hearts from type 2 diabetic mice. Am J Physiol Heart Circ Physiol 296: H1373-H1379, 2009.
21. Boudina S and Abel ED. Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord 11: 31-39, 2010.
22. Boudina S, Sena S, O'Neill BT, Tathireddy P, Young ME, and Abel ED. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112: 2686-2695, 2005.
23. Boudina S, Sena S, Theobald H, Sheng X, Wright JJ, Hu XX, Aziz S, Johnson JI, Bugger H, Zaha VG, and Abel ED. Mitochondrial energetics in the heart in obesityrelated diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 56: 2457-2466, 2007.
24. Boveris A, Oshino N, and Chance B. The cellular production of hydrogen peroxide. Biochem J 128: 617-630, 1972.
25. Boyer JK, Thanigaraj S, Schechtman KB, and Perez JE. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol 93: 870-875, 2004.
26. Brookheart RT, Michel CI, and Schaffer JE. As a matter of fat. Cell Metab 10: 9-12, 2009.
27. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
28. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54: 1615-1625, 2005.
29. Buchanan J, Mazumder PK, Hu P, Chakrabarti G, Roberts MW, Yun UJ, Cooksey RC, Litwin SE, and Abel ED. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 146: 5341-5349, 2005.
30. Bugger H and Abel ED. Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. Clin Sci (Lond) 114: 195-210, 2008.
31. Bugger H and Abel ED. Mitochondria in the diabetic heart. Cardiovasc Res 88: 229-240, 2010.
32. Bugger H, Boudina S, Hu XX, Tuinei J, Zaha VG, Theobald HA, Yun UJ, McQueen AP, Wayment B, Litwin SE, and Abel ED. Type 1 diabetic akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3. Diabetes 57: 2924-2932, 2008.
33. Burgoyne JR, Mongue-Din H, Eaton P, and Shah AM. Redox signaling in cardiac physiology and pathology. Circ Res 111: 1091-1106, 2012.
34. Burgoyne JR, Oka S, Ale-Agha N, and Eaton P. Hydrogen peroxide sensing and signaling by protein kinases in the cardiovascular system. Antioxid Redox Signal 18: 1042-1052, 2013.
35. Butler AA and Kozak LP. A recurring problem with the analysis of energy expenditure in genetic models expressing lean and obese phenotypes. Diabetes 59: 323-329, 2010.
36. Camara AK, Bienengraeber M, and Stowe DF. Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury. Front Physiol 2: 13, 2011.
37. Carley AN and Severson DL. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta 1734: 112-126, 2005.
38. Chance B, Sies H, and Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 59: 527-605, 1979.
39. Chatham JC and Seymour AM. Cardiac carbohydrate metabolism in Zucker diabetic fatty rats. Cardiovasc Res 55: 104-112, 2002.
40. Chen L, Na R, Gu M, Salmon AB, Liu Y, Liang H, Qi W, Van Remmen H, Richardson A, and Ran Q. Reduction of mitochondrial H2O2 by overexpressing peroxiredoxin 3 improves glucose tolerance in mice. Aging Cell 7: 866-878, 2008.
41. Chen X, Mele J, Giese H, Van Remmen H, Dolle ME, Steinhelper M, Richardson A, and Vijg J. A strategy for the ubiquitous overexpression of human catalase and CuZn superoxide dismutase genes in transgenic mice. Mech Ageing Dev 124: 219-227, 2003.
42. Chouchani ET, Methner C, Nadtochiy SM, Logan A, Pell VR, Ding S, James AM, Cocheme HM, Reinhold J, Lilley KS, Partridge L, Fearnley IM, Robinson AJ, Hartley RC, Smith RA, Krieg T, Brookes PS, and Murphy MP. Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I. Nat Med 19: 753-759, 2013.
43. Christians ES and Benjamin IJ. Proteostasis and REDOX state in the heart. Am J Physiol Heart Circ Physiol 302: H24-H37, 2012.
44. Clementi E, Brown GC, Feelisch M, and Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci U S A 95: 7631-7636, 1998.
45. Cohen-Solal A, Beauvais F, and Logeart D. Heart failure and diabetes mellitus: epidemiology and management of an alarming association. J Card Fail 14: 615-625, 2008.
46. Connelly KA, Advani A, Advani SL, Zhang Y, Kim YM, Shen V, Thai K, Kelly DJ, and Gilbert RE. Impaired cardiac anti-oxidant activity in diabetes: human and correlative experimental studies. Acta Diabetol 51: 771-782, 2014.
47. Cortassa S, Aon JC, and Aon MA. Fluxes of carbon, phosphorylation, and redox intermediates during growth of saccharomyces cerevisiae on different carbon sources. Biotechnol Bioeng 47: 193-208, 1995.
48. Cortassa S, Aon MA, Iglesias AA, Aon JC, and Lloyd D. An Introduction to Metabolic and Cellular Engineering. Singapore: World Scientific Publishers, 2012, p. 448.
49. Cortassa S, Aon MA, Marban E, Winslow RL, and O'Rourke B. An integrated model of cardiac mitochondrial energy metabolism and calcium dynamics. Biophys J 84: 2734-2755, 2003.
50. Cortassa S, Aon MA, O'Rourke B, Jacques R, Tseng HJ, Marban E, and Winslow RL. A computational model integrating electrophysiology, contraction, and mitochondrial bioenergetics in the ventricular myocyte. Biophys J 91: 1564-1589, 2006.
51. Cortassa S, Bhatt N, Aon MA, Shen XX, O'Rourke B, and Gao WD. Contractile and mitochondrial dysfunction in heart trabeculae from diabetic rats. Mitochondrion 12: 581, 2012.
52. Cortassa S, O'Rourke B, and Aon MA. Redox-Optimized ROS Balance and the relationship between mitochondrial respiration and ROS. Biochim Biophys Acta 1837: 287-295, 2014.
53. Cortassa S, O'Rourke B, Winslow RL, and Aon MA. Control and regulation of mitochondrial energetics in an integrated model of cardiomyocyte function. Biophys J 96: 2466-2478, 2009.
54. Cortassa S, O'Rourke B, Winslow RL, and Aon MA. Control and regulation of integrated mitochondrial function in metabolic and transport networks. Int J Mol Sci 10: 1500-1513, 2009.
55. Cortassa S, Tocchetti CG, Caceres V, Paolocci N, and Aon MA. Aldose reductase inhibition or activation of transketolase offset adverse metabolic remodeling improving function in type 2 diabetes myocytes exposed to hyperglycemia. Biophys J 104: 159A, 2013.
56. Cox AG, Winterbourn CC, and Hampton MB. Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem J 425: 313-325, 2010.
57. Crawford PA and Schaffer JE. Metabolic stress in the myocardium: adaptations of gene expression. J Mol Cell Cardiol 55: 130-138, 2013.
58. Croston TL, Thapa D, Holden AA, Tveter KJ, Lewis SE, Shepherd DL, Nichols CE, Long DM, Olfert IM, Jagannathan R, and Hollander JM. Functional deficiencies of subsarcolemmal mitochondria in the type 2 diabetic human heart. Am J Physiol Heart Circ Physiol 307: H54-H65, 2014.
59. D'Autreaux B and Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8: 813-824, 2007.
60. Dabkowski ER, Baseler WA, Williamson CL, Powell M, Razunguzwa TT, Frisbee JC, and Hollander JM. Mitochondrial dysfunction in the type 2 diabetic heart is associated with alterations in spatially distinct mitochondrial proteomes. Am J Physiol Heart Circ Physiol 299: H529-H540, 2010.
61. Dabkowski ER, Williamson CL, Bukowski VC, Chapman RS, Leonard SS, Peer CJ, Callery PS, and Hollander JM. Diabetic cardiomyopathy-associated dysfunction in spatially distinct mitochondrial subpopulations. Am J Physiol Heart Circ Physiol 296: H359-H369, 2009.
62. Dalton TP, Shertzer HG, and Puga A. Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol Toxicol 39: 67-101, 1999.
63. Della Rosa F, Despas F, Labrunée M, Vaccaro A, Galinier M, Senard JM, Parati G, and Pathak A. Hyperglycemia in congestive heart failure patients is associated to sympathetic overactivity. Circulation 128: A16277, 2013.
64. Ding Y, Yamada S, Wang KY, Shimajiri S, Guo X, Tanimoto A, Murata Y, Kitajima S, Watanabe T, Izumi H, Kohno K, and Sasaguri Y. Overexpression of peroxiredoxin 4 protects against high-dose streptozotocininduced diabetes by suppressing oxidative stress and cytokines in transgenic mice. Antioxid Redox Signal 13: 1477-1490, 2010.
65. Dokken BB, Saengsirisuwan V, Kim JS, Teachey MK, and Henriksen EJ. Oxidative stress-induced insulin resistance in rat skeletal muscle: role of glycogen synthase kinase-3. Am J Physiol Endocrinol Metab 294: E615-E621, 2008.
66. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
67. Eager KR, Roden LD, and Dulhunty AF. Actions of sulfhydryl reagents on single ryanodine receptor Ca(2+)-release channels from sheep myocardium. Am J Physiol 272: C1908-C1918, 1997.
68. Eaton P, Wright N, Hearse DJ, and Shattock MJ. Glyceraldehyde phosphate dehydrogenase oxidation during cardiac ischemia and reperfusion. J Mol Cell Cardiol 34: 1549-1560, 2002.
69. Finkel T. Radical medicine: treating ageing to cure disease. Nat Rev Mol Cell Biol 6: 971-976, 2005.
70. Fisher-Wellman KH, Mattox TA, Thayne K, Katunga LA, La Favor JD, Neufer PD, Hickner RC, Wingard CJ, and Anderson EJ. Novel role for thioredoxin reductase-2 in mitochondrial redox adaptations to obesogenic diet and exercise in heart and skeletal muscle. J Physiol 591: 3471-3486, 2013.
71. Fisher-Wellman KH and Neufer PD. Linking mitochondrial bioenergetics to insulin resistance via redox biology. Trends Endocrinol Metab 23: 142-153, 2012.
72. Flarsheim CE, Grupp IL, and Matlib MA. Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart. Am J Physiol 271: H192-H202, 1996.
73. Fox CS, Coady S, Sorlie PD, D'Agostino RB, Sr., Pencina MJ, Vasan RS, Meigs JB, Levy D, and Savage PJ. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation 115: 1544-1550, 2007.
74. Fritzen AJ, Grunnet N, and Quistorff B. Flux control analysis of mitochondrial oxidative phosphorylation in rat skeletal muscle: pyruvate and palmitoyl-carnitine as substrates give different control patterns. Eur J Appl Physiol 101: 679-689, 2007.
75. Gardner CD, Eguchi S, Reynolds CM, Eguchi K, Frank GD, and Motley ED. Hydrogen peroxide inhibits insulin signaling in vascular smooth muscle cells. Exp Biol Med (Maywood) 228: 836-842, 2003.
76. Ge F, Hu C, Hyodo E, Arai K, Zhou S, Lobdell Ht, Walewski JL, Homma S, and Berk PD. Cardiomyocyte triglyceride accumulation and reduced ventricular function in mice with obesity reflect increased long chain Fatty Acid uptake and de novo Fatty Acid synthesis. J Obes 2012: 205648, 2012.
77. Giacco F and Brownlee M. Oxidative stress and diabetic complications. Circ Res 107: 1058-1070, 2010.
78. Giannini S, Serio M, and Galli A. Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity. J Endocrinol Invest 27: 982-991, 2004.
79. Gibbs CL and Loiselle DS. Cardiac basal metabolism. Jpn J Physiol 51: 399-426, 2001.
80. Go YM and Jones DP. Redox compartmentalization in eukaryotic cells. Biochim Biophys Acta 1780: 1273-1290, 2008.
81. Goldberg IJ, Trent CM, and Schulze PC. Lipid metabolism and toxicity in the heart. Cell Metab 15: 805-812, 2012.
82. Goto Y, Hotta N, Shigeta Y, Sakamoto N, and Kikkawa R. Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled doubleblind study. Biomed Pharmacother 49: 269-277, 1995.
83. Greenberg AS, Coleman RA, Kraemer FB, McManaman JL, Obin MS, Puri V, Yan QW, Miyoshi H, and Mashek DG. The role of lipid droplets in metabolic disease in rodents and humans. J Clin Invest 121: 2102-2110, 2011.
84. Gupta A, Akki A, Wang Y, Leppo MK, Chacko VP, Foster DB, Caceres V, Shi S, Kirk JA, Su J, Lai S, Paolocci N, Steenbergen C, Gerstenblith G, and Weiss RG. Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved. J Clin Invest 122: 291-302, 2012.
85. Gustafsson AB and Gottlieb RA. Heart mitochondria: gates of life and death. Cardiovasc Res 77: 334-343, 2008.
86. Hackenbrock CR, Chazotte B, and Gupte SS. The random collision model and a critical assessment of diffusion and collision in mitochondrial electron transport. J Bioenerg Biomembr 18: 331-368, 1986.
87. Hafstad AD, Solevag GH, Severson DL, Larsen TS, and Aasum E. Perfused hearts from Type 2 diabetic (db/db) mice show metabolic responsiveness to insulin. Am J Physiol Heart Circ Physiol 290: H1763-H1769, 2006.
88. Handy DE and Loscalzo J. Redox regulation of mitochondrial function. Antioxid Redox Signal 16: 1323-1367, 2012.
89. Hansford RG and Zorov D. Role of mitochondrial calcium transport in the control of substrate oxidation. Mol Cell Biochem 184: 359-369, 1998.
90. Harmancey R and Taegtmeyer H. The complexities of diabetic cardiomyopathy: lessons from patients and animal models. Curr Diab Rep 8: 243-248, 2008.
91. Harmancey R, Wilson CR, and Taegtmeyer H. Adaptation and maladaptation of the heart in obesity. Hypertension 52: 181-187, 2008.
92. Herlein JA, Fink BD, O'Malley Y, and Sivitz WI. Superoxide and respiratory coupling in mitochondria of insulin-deficient diabetic rats. Endocrinology 150: 46-55, 2009.
93. Hochli M and Hackenbrock CR. Fluidity in mitochondrial membranes: thermotropic lateral translational motion of intramembrane particles. Proc Natl Acad Sci U S A 73: 1636-1640, 1976.
94. Hoehn KL, Salmon AB, Hohnen-Behrens C, Turner N, Hoy AJ, Maghzal GJ, Stocker R, Van Remmen H, Kraegen EW, Cooney GJ, Richardson AR, and James DE. Insulin resistance is a cellular antioxidant defense mechanism. Proc Natl Acad Sci U S A 106: 17787-17792, 2009.
95. Hoek JB and Rydstrom J. Physiological roles of nicotinamide nucleotide transhydrogenase. Biochem J 254: 1-10, 1988.
96. Hoffman DL and Brookes PS. Oxygen sensitivity of mitochondrial reactive oxygen species generation depends on metabolic conditions. J Biol Chem 284: 16236-16245, 2009.
97. Hotta N, Kawamori R, Fukuda M, and Shigeta Y. Longterm clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy. Diabet Med 29: 1529-1533, 2012.
98. How OJ, Aasum E, Severson DL, Chan WY, Essop MF, and Larsen TS. Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes 55: 466-473, 2006.
99. Hue L and Taegtmeyer H. The Randle cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab 297: E578-E591, 2009.
100. Jang YC, Perez VI, Song W, Lustgarten MS, Salmon AB, Mele J, Qi W, Liu Y, Liang H, Chaudhuri A, Ikeno Y, Epstein CJ, Van Remmen H, and Richardson A. Overexpression of Mn superoxide dismutase does not increase life span in mice. J Gerontol A Biol Sci Med Sci 64: 1114-1125, 2009.
101. Jang YC and Van Remmen H. The mitochondrial theory of aging: insight from transgenic and knockout mouse models. Exp Gerontol 44: 256-260, 2009.
102. Jones DP and Go YM. Redox compartmentalization and cellular stress. Diabetes Obes Metab 12 Suppl 2: 116-125, 2010.
103. Kaludercic N, Deshwal S, and Di Lisa F. Reactive oxygen species and redox compartmentalization. Front Physiol 5: 1-15, 2014.
104. Kannel WB and McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 241: 2035-2038, 1979.
105. Kembro JM, Aon MA, Winslow RL, O'Rourke B, and Cortassa S. Integrating mitochondrial energetics, redox and ROS metabolic networks: a two-compartment model. Biophys J 104: 332-343, 2013.
106. Kembro JM, Cortassa S, and Aon MA. Complex oscillatory redox dynamics with signaling potential at the edge between normal and pathological mitochondrial function. Front Physiol 5: 257, 2014.
107. Kembro JM, Cortassa S, and Aon MA. Mitochondrial ROS and arrhythmias. In: Systems Biology of Free Radicals and Anti-Oxidants, edited by Laher I. Berlin Heidelberg: Springer-Verlag, 2014.
108. Kienesberger PC, Pulinilkunnil T, Nagendran J, and Dyck JR. Myocardial triacylglycerol metabolism. J Mol Cell Cardiol 55: 101-110, 2013.
109. Kohler JJ, Cucoranu I, Fields E, Green E, He S, Hoying A, Russ R, Abuin A, Johnson D, Hosseini SH, Raper CM, and Lewis W. Transgenic mitochondrial superoxide dismutase and mitochondrially targeted catalase prevent antiretroviral-induced oxidative stress and cardiomyopathy. Lab Invest 89: 782-790, 2009.
110. Koves TR, Sparks LM, Kovalik JP, Mosedale M, Arumugam R, DeBalsi KL, Everingham K, Thorne L, Phielix E, Meex RC, Kien CL, Hesselink MK, Schrauwen P, and Muoio DM. PPARgamma coactivator-1alpha contributes to exercise-induced regulation of intramuscular lipid droplet programming in mice and humans. J Lipid Res 54: 522-534, 2013.
111. Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, and Vercesi AE. Mitochondria and reactive oxygen species. Free Radic Biol Med 47: 333-343, 2009.
112. Kuo TH, Moore KH, Giacomelli F, and Wiener J. Defective oxidative metabolism of heart mitochondria from genetically diabetic mice. Diabetes 32: 781-787, 1983.
113. Kuramoto K, Okamura T, Yamaguchi T, Nakamura TY, Wakabayashi S, Morinaga H, Nomura M, Yanase T, Otsu K, Usuda N, Matsumura S, Inoue K, Fushiki T, Kojima Y, Hashimoto T, Sakai F, Hirose F, and Osumi T. Perilipin 5, a lipid droplet-binding protein, protects heart from oxidative burden by sequestering fatty acid from excessive oxidation. J Biol Chem 287: 23852-23863, 2012.
114. Lashin OM, Szweda PA, Szweda LI, and Romani AM. Decreased complex II respiration and HNE-modified SDH subunit in diabetic heart. Free Radic Biol Med 40: 886-896, 2006.
115. Lasker RD. The diabetes control and complications trial. Implications for policy and practice. N Engl J Med 329: 1035-1036, 1993.
116. Letellier T, Malgat M, and Mazat JP. Control of oxidative phosphorylation in rat muscle mitochondria: implications for mitochondrial myopathies. Biochim Biophys Acta 1141: 58-64, 1993.
117. Li L, Kaifu T, Obinata M, and Takai T. Peroxiredoxin IIIdeficiency sensitizes macrophages to oxidative stress. J Biochem 145: 425-427, 2009.
118. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, and Epstein CJ. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11: 376-381, 1995.
119. Listenberger LL, Han X, Lewis SE, Cases S, Farese RV, Jr., Ory DS, and Schaffer JE. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A 100: 3077-3082, 2003.
120. Liu T, Brown DA, and O'Rourke B. Role of mitochondrial dysfunction in cardiac glycoside toxicity. J Mol Cell Cardiol 49: 728-736, 2010.
121. Liu T and O'Rourke B. Enhancing mitochondrial Ca2+ uptake in myocytes from failing hearts restores energy supply and demand matching. Circ Res 103: 279-288, 2008.
122. Loh K, Deng H, Fukushima A, Cai X, Boivin B, Galic S, Bruce C, Shields BJ, Skiba B, Ooms LM, Stepto N, Wu B, Mitchell CA, Tonks NK, Watt MJ, Febbraio MA, Crack PJ, Andrikopoulos S, and Tiganis T. Reactive oxygen species enhance insulin sensitivity. Cell Metab 10: 260-272, 2009.
123. Lopaschuk GD. Metabolic abnormalities in the diabetic heart. Heart Fail Rev 7: 149-159, 2002.
124. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, and Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev 90: 207-258, 2010.
125. Louch WE, Stokke MK, Sjaastad I, Christensen G, and Sejersted OM. No rest for the weary: diastolic calcium homeostasis in the normal and failing myocardium. Physiology (Bethesda) 27: 308-323, 2012.
126. Lowell BB and Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 307: 384-387, 2005.
127. Maack C and O'Rourke B. Excitation-contraction coupling and mitochondrial energetics. Basic Res Cardiol 102: 369-392, 2007.
128. Maisch B, Alter P, and Pankuweit S. Diabetic cardiomyopathy - fact or fiction? Herz 36: 102-115, 2011.
129. Marengo JJ, Hidalgo C, and Bull R. Sulfhydryl oxidation modifies the calcium dependence of ryanodine-sensitive calcium channels of excitable cells. Biophys J 74: 1263-1277, 1998.
130. Martinou JC and Youle RJ. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 21: 92-101, 2011.
131. Matsushima S, Ide T, Yamato M, Matsusaka H, Hattori F, Ikeuchi M, Kubota T, Sunagawa K, Hasegawa Y, Kurihara T, Oikawa S, Kinugawa S, and Tsutsui H. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 113: 1779-1786, 2006.
132. Mazumder PK, O'Neill BT, Roberts MW, Buchanan J, Yun UJ, Cooksey RC, Boudina S, and Abel ED. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 53: 2366-2374, 2004.
133. Mebazaa A, Gayat E, Lassus J, Meas T, Mueller C, Maggioni A, Peacock F, Spinar J, Harjola VP, van Kimmenade R, Pathak A, Mueller T, Tavazzi L, Disomma S, Metra M, Pascual-Figal D, Laribi S, Logeart D, Nouira S, Sato N, Parenica J, Deye N, Boukef R, Collet C, Van den Berghe G, Cohen-Solal A, and Januzzi JL, Jr. Association between elevated blood glucose and outcome in acute heart failure: results from an international observational cohort. J Am Coll Cardiol 61: 820-829, 2013.
134. Mele J, Van Remmen H, Vijg J, and Richardson A. Characterization of transgenic mice that overexpress both copper zinc superoxide dismutase and catalase. Antioxid Redox Signal 8: 628-638, 2006.
135. Montaigne D, Marechal X, Coisne A, Debry N, Modine T, Fayad G, Potelle C, El Arid JM, Mouton S, Sebti Y, Duez H, Preau S, Remy-Jouet I, Zerimech F, Koussa M, Richard V, Neviere R, Edme JL, Lefebvre P, and Staels B. Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients. Circulation 130: 554-564, 2014.
136. Moreno-Lastres D, Fontanesi F, Garcia-Consuegra I, Martin MA, Arenas J, Barrientos A, and Ugalde C. Mitochondrial complex I plays an essential role in human respirasome assembly. Cell Metab 15: 324-335, 2012.
137. Muoio DM and Neufer PD. Lipid-induced mitochondrial stress and insulin action in muscle. Cell Metab 15: 595-605, 2012.
138. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 417: 1-13, 2009.
139. Muscogiuri G, Salmon AB, Aguayo-Mazzucato C, Li M, Balas B, Guardado-Mendoza R, Giaccari A, Reddick RL, Reyna SM, Weir G, Defronzo RA, Van Remmen H, and Musi N. Genetic disruption of SOD1 gene causes glucose intolerance and impairs beta-cell function. Diabetes 62: 4201-4207, 2013.
140. Negre-Salvayre A, Salvayre R, Auge N, Pamplona R, and Portero-Otin M. Hyperglycemia and glycation in diabetic complications. Antioxid Redox Signal 11: 3071-3109, 2009.
141. Netticadan T, Temsah RM, Kent A, Elimban V, and Dhalla NS. Depressed levels of Ca2+-cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart. Diabetes 50: 2133-2138, 2001.
142. Neubauer S. The failing heart - an engine out of fuel. N Engl J Med 356: 1140-1151, 2007.
143. Newsholme P, Gaudel C, and Krause M. Mitochondria and diabetes. An intriguing pathogenetic role. Adv Exp Med Biol 942: 235-247, 2012.
144. Nguyen T, Nioi P, and Pickett CB. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 284: 13291-13295, 2009.
145. Nickel A, Loffler J, and Maack C. Myocardial energetics in heart failure. Basic Res Cardiol 108: 358, 2013.
146. Nishida K, Kyoi S, Yamaguchi O, Sadoshima J, and Otsu K. The role of autophagy in the heart. Cell Death Differ 16: 31-38, 2009.
147. Nunnari J and Suomalainen A. Mitochondria: in sickness and in health. Cell 148: 1145-1159, 2012.
148. Oka S, Hsu CP, and Sadoshima J. Regulation of cell survival and death by pyridine nucleotides. Circ Res 111: 611-627, 2012.
149. Pacifici F, Arriga R, Sorice GP, Capuani B, Scioli MG, Pastore D, Donadel G, Bellia A, Caratelli S, Coppola A, Ferrelli F, Federici M, Sconocchia G, Tesauro M, Sbraccia P, Della-Morte D, Giaccari A, Orlandi A, and Lauro D. Peroxiredoxin 6, a novel player in the pathogenesis of diabetes. Diabetes 63: 3210-3220, 2014.
150. Paulsen CE and Carroll KS. Orchestrating redox signaling networks through regulatory cysteine switches. ACS Chem Biol 5: 47-62, 2010.
151. Perez VI, Lew CM, Cortez LA, Webb CR, Rodriguez M, Liu Y, Qi W, Li Y, Chaudhuri A, Van Remmen H, Richardson A, and Ikeno Y. Thioredoxin 2 haploinsufficiency in mice results in impaired mitochondrial function and increased oxidative stress. Free Radic Biol Med 44: 882-892, 2008.
152. Picard M and Turnbull DM. Linking the metabolic state and mitochondrial DNA in chronic disease, health, and aging. Diabetes 62: 672-678, 2013.
153. Picard M, Zhang J, Hancock S, Derbeneva O, Golhar R, Golik P, O'Hearn S, Levy S, Potluri P, Lvova M, Davila A, Lin CS, Perin JC, Rappaport EF, Hakonarson H, Trounce IA, Procaccio V, and Wallace DC. Progressive increase in mtDNA 3243A>G heteroplasmy causes abrupt transcriptional reprogramming. Proc Natl Acad Sci U S A 111: E4033-E4042, 2014.
154. Pierce GN and Dhalla NS. Heart mitochondrial function in chronic experimental diabetes in rats. Can J Cardiol 1: 48-54, 1985.
155. Pourova J, Kottova M, Voprsalova M, and Pour M. Reactive oxygen and nitrogen species in normal physiological processes. Acta Physiol (Oxf) 198: 15-35, 2010.
156. Rains JL and Jain SK. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 50: 567-575, 2011.
157. Ramasamy R and Goldberg IJ. Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model. Circ Res 106: 1449-1458, 2010.
158. Ran Q, Liang H, Gu M, Qi W, Walter CA, Roberts LJ, 2nd, Herman B, Richardson A, and Van Remmen H. Transgenic mice overexpressing glutathione peroxidase 4 are protected against oxidative stress-induced apoptosis. J Biol Chem 279: 55137-55146, 2004.
159. Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14: 263-283, 1998.
160. Reusch JE and Wang CC. Cardiovascular disease in diabetes: where does glucose fit in? J Clin Endocrinol Metab 96: 2367-2376, 2011.
161. Rhee SG and Woo HA. Multiple functions of peroxiredoxins: peroxidases, sensors and regulators of the intracellular messenger H(2)O(2), and protein chaperones. Antioxid Redox Signal 15: 781-794, 2011.
162. Riddle MC. Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Circulation 122: 844-846, 2010.
163. Rindler PM, Crewe CL, Fernandes J, Kinter M, and Szweda LI. Redox regulation of insulin sensitivity due to enhanced fatty acid utilization in the mitochondria. Am J Physiol Heart Circ Physiol 305: H634-H643, 2013.
164. Roden M. Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes. Int J Obes (Lond) 29 Suppl 2: S111-S115, 2005.
165. Roede JR, Go YM, and Jones DP. Redox equivalents and mitochondrial bioenergetics. Methods Mol Biol 810: 249-280, 2012.
166. Rolfe DF and Brown GC. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev 77: 731-758, 1997.
167. Ron D. Proteotoxicity in the endoplasmic reticulum: lessons from the Akita diabetic mouse. J Clin Invest 109: 443-445, 2002.
168. Roy TM, Broadstone VL, Peterson HR, Snider HL, Cyrus J, Fell R, Rothchild AH, Samols E, and Pfeifer MA. The effect of an aldose reductase inhibitor on cardiovascular performance in patients with diabetes mellitus. Diabetes Res Clin Pract 10: 91-97, 1990.
169. Rydstrom J. Mitochondrial transhydrogenase - a key enzyme in insulin secretion and, potentially, diabetes. Trends Biochem Sci 31: 355-358, 2006.
170. Santos CX, Anilkumar N, Zhang M, Brewer AC, and Shah AM. Redox signaling in cardiac myocytes. Free Radic Biol Med 50: 777-793, 2011.
171. Schafer FQ and Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30: 1191-1212, 2001.
172. Schilling JD and Mann DL. Diabetic cardiomyopathy: bench to bedside. Heart Fail Clin 8: 619-631, 2012.
173. Schrauwen P, Schrauwen-Hinderling V, Hoeks J, and Hesselink MK. Mitochondrial dysfunction and lipotoxicity. Biochim Biophys Acta 1801: 266-271, 2010.
174. Shen X, Zheng S, Metreveli NS, and Epstein PN. Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy. Diabetes 55: 798-805, 2006.
175. Shen X, Zheng S, Thongboonkerd V, Xu M, Pierce WM, Jr., Klein JB, and Epstein PN. Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. Am J Physiol Endocrinol Metab 287: E896-E905, 2004.
176. Sies H and Jones DP. Oxidative stress. In: Encyclopedia of Stress, edited by Fink G. San Diego, CA: Elsevier, 2007, pp. 45-48.
177. Silverthorn DU, Ober WC, Garrison CW, Silverthorn AC, and Johnson BR. Human Physiology. An Integrated Approach. San Francisco CA: Pearson Benjamin Cummings, 2009.
178. Singh R and Cuervo AM. Lipophagy: connecting autophagy and lipid metabolism. Int J Cell Biol 2012: 282041, 2012.
179. Sivitz WI and Yorek MA. Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid Redox Signal 12: 537-577, 2010.
180. Solaini G and Harris DA. Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem J 390: 377-394, 2005.
181. St-Pierre J, Buckingham JA, Roebuck SJ, and Brand MD. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem 277: 44784-44790, 2002.
182. Stanley BA, Sivakumaran V, Shi S, McDonald I, Lloyd D, Watson WH, Aon MA, and Paolocci N. Thioredoxin reductase-2 is essential for keeping low levels of H(2)O(2) emission from isolated heart mitochondria. J Biol Chem 286: 33669-33677, 2011.
183. Stowe DF and Camara AK. Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. Antioxid Redox Signal 11: 1373-1414, 2009.
184. Styskal J, Van Remmen H, Richardson A, and Salmon AB. Oxidative stress and diabetes: what can we learn about insulin resistance from antioxidant mutant mouse models? Free Radic Biol Med 52: 46-58, 2012.
185. Taegtmeyer H, McNulty P, and Young ME. Adaptation and maladaptation of the heart in diabetes: Part I: general concepts. Circulation 105: 1727-1733, 2002.
186. Taylor ER, Hurrell F, Shannon RJ, Lin TK, Hirst J, and Murphy MP. Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J Biol Chem 278: 19603-19610, 2003.
187. Tocchetti CG, Caceres V, Stanley BA, Xie C, Shi S, Watson WH, O'Rourke B, Spadari-Bratfisch RC, Cortassa S, Akar FG, Paolocci N, and Aon MA. GSH or palmitate preserves mitochondrial energetic/redox balance, preventing mechanical dysfunction in metabolically challenged myocytes/hearts from type 2 diabetic mice. Diabetes 61: 3094-3105, 2012.
188. Trost SU, Belke DD, Bluhm WF, Meyer M, Swanson E, and Dillmann WH. Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 51: 1166-1171, 2002.
189. Turko IV, Li L, Aulak KS, Stuehr DJ, Chang JY, and Murad F. Protein tyrosine nitration in the mitochondria from diabetic mouse heart. Implications to dysfunctional mitochondria in diabetes. J Biol Chem 278: 33972-33977, 2003.
190. Turko IV and Murad F. Quantitative protein profiling in heart mitochondria from diabetic rats. J Biol Chem 278: 35844-35849, 2003.
191. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 552: 335-344, 2003.
192. Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, Alroy J, Wu M, Py BF, Yuan J, Deeney JT, Corkey BE, and Shirihai OS. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 27: 433-446, 2008.
193. Ussher JR. The role of cardiac lipotoxicity in the pathogenesis of diabetic cardiomyopathy. Expert Rev Cardiovasc Ther 12: 345-358, 2014.
194. Ussher JR, Jaswal JS, and Lopaschuk GD. Pyridine nucleotide regulation of cardiac intermediary metabolism. Circ Res 111: 628-641, 2012.
195. Van Remmen H, Salvador C, Yang H, Huang TT, Epstein CJ, and Richardson A. Characterization of the antioxidant status of the heterozygous manganese superoxide dis- mutase knockout mouse. Arch Biochem Biophys 363: 91-97, 1999.
196. Vetter R, Rehfeld U, Reissfelder C, Weiss W, Wagner KD, Gunther J, Hammes A, Tschope C, Dillmann W, and Paul M. Transgenic overexpression of the sarcoplasmic reticulum Ca2+ ATPase improves reticular Ca2+ handling in normal and diabetic rat hearts. FASEB J 16: 1657-1659, 2002.
197. Wall SB, Oh JY, Diers AR, and Landar A. Oxidative modification of proteins: an emerging mechanism of cell signaling. Front Physiol 3: 369, 2012.
198. Wallace DC and Chalkia D. Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease. Cold Spring Harb Perspect Biol 5: a021220, 2013.
199. Walther TC and Farese RV, Jr. Lipid droplets and cellular lipid metabolism. Annu Rev Biochem 81: 687-714, 2012.
200. Wang CC and Reusch JE. Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival. Am J Cardiol 110: 58B-68B, 2012.
201. Wang H, Sreenevasan U, Hu H, Saladino A, Polster BM, Lund LM, Gong DW, Stanley WC, and Sztalryd C. Perilipin 5, a lipid droplet-associated protein, provides physical and metabolic linkage to mitochondria. J Lipid Res 52: 2159-2168, 2011.
202. Wang H, Sreenivasan U, Gong DW, O'Connell KA, Dabkowski ER, Hecker PA, Ionica N, Konig M, Mahurkar A, Sun Y, Stanley WC, and Sztalryd C. Cardiomyocytespecific perilipin 5 overexpression leads to myocardial steatosis and modest cardiac dysfunction. J Lipid Res 54: 953-965, 2013.
203. Wang H and Sztalryd C. Oxidative tissue: perilipin 5 links storage with the furnace. Trends Endocrinol Metab 22: 197-203, 2011.
204. Wang P, Lloyd SG, and Chatham JC. Impact of high glucose/high insulin and dichloroacetate treatment on carbohydrate oxidation and functional recovery after low-flow ischemia and reperfusion in the isolated perfused rat heart. Circulation 111: 2066-2072, 2005.
205. Wang P, Lloyd SG, Zeng H, Bonen A, and Chatham JC. Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 288: H2102-H2110, 2005.
206. Wang X, Phelan SA, Forsman-Semb K, Taylor EF, Petros C, Brown A, Lerner CP, and Paigen B. Mice with targeted mutation of peroxiredoxin 6 develop normally but are susceptible to oxidative stress. J Biol Chem 278: 25179-25190, 2003.
207. Weibel ER and Hoppeler H. Exercise-induced maximal metabolic rate scales with muscle aerobic capacity. J Exp Biol 208: 1635-1644, 2005.
208. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, van den Enden M, Kilo C, and Tilton RG. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42: 801-813, 1993.
209. Wojtczak L and Schonfeld P. Effect of fatty acids on energy coupling processes in mitochondria. Biochim Biophys Acta 1183: 41-57, 1993.
210. Yant LJ, Ran Q, Rao L, Van Remmen H, Shibatani T, Belter JG, Motta L, Richardson A, and Prolla TA. The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. Free Radic Biol Med 34: 496-502, 2003.
211. Ye G, Metreveli NS, Donthi RV, Xia S, Xu M, Carlson EC, and Epstein PN. Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 53: 1336-1343, 2004.
212. Yoshida T, Maulik N, Engelman RM, Ho YS, and Das DK. Targeted disruption of the mouse Sod I gene makes the hearts vulnerable to ischemic reperfusion injury. Circ Res 86: 264-269, 2000.
213. Young ME, Guthrie PH, Razeghi P, Leighton B, Abbasi S, Patil S, Youker KA, and Taegtmeyer H. Impaired longchain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes 51: 2587-2595, 2002.
214. Young ME, McNulty P, and Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation 105: 1861-1870, 2002.
215. Yu EP and Bennett MR. Mitochondrial DNA damage and atherosclerosis. Trends Endocrinol Metab 25: 481-487, 2014.
216. Yu Z, Quamme GA, and McNeill JH. Depressed [Ca2+]i responses to isoproterenol and cAMP in isolated cardiomyocytes from experimental diabetic rats. Am J Physiol 266: H2334-H2342, 1994.
217. Zhang J, Graham DG, Montine TJ, and Ho YS. Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase. J Neuropathol Exp Neurol 59: 53-61, 2000.
218. Zhong Y, Ahmed S, Grupp IL, and Matlib MA. Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts. Am J Physiol Heart Circ Physiol 281: H1137-H1147, 2001.
219. Zhou L, Aon MA, Almas T, Cortassa S, Winslow RL, and O'Rourke B. A reaction-diffusion model of ROS-induced ROS release in a mitochondrial network. PLoS Comput Biol 6: e1000657, 2010.